South Korea Faces 15 Percent Tariffs on Pharmaceuticals as Trump Trade War Escalates in 2026

Welcome to South Korea Tariff News and Tracker, your essential update on how U.S. trade policies under President Trump are reshaping global markets, with a sharp focus on the Korean Peninsula. Listeners, as of late April 2026, South Korea faces a 15% ad valorem duty on key pharmaceutical imports into the U.S., alongside tariffs from European Union, Japan, Korea, or Switzerland and Liechtenstein, according to the comprehensive Trump Tariff Tracker from Baker Botts reported on JDSupra April 27. These rates, implemented April 2, hit patented products and ingredients hard, pushing Korean exporters like Samsung Biologics and Celltrion to rethink supply chains amid Trump's escalating trade war. Fortune's April 29 analysis reveals boards at tariff-exposed firms, including those with Korean ties, have shielded CEO pay—RTX's Christopher Calio pocketed $27.7 million despite trade hits—showing how U.S. executives insulate from the pain Korean manufacturers endure. Broader Section 301 probes by the USTR, with hearings wrapping today on April 29, scrutinize 60 economies including South Korea for forced labor import bans, per JDSupra, risking further duties if enforcement falls short. Markets reflect the strain: South Korea's KOSPI climbed 0.75% amid oil spikes to $112 Brent, as Fortune notes U.S. assets outperform while allies like Korea grapple with Trump's reciprocal tariffs—now at 10% baseline plus country-specific hikes up to 50%. No dedicated U.S.-South Korea deal eases this yet, unlike US-UK or US-Japan pacts, leaving Hyundai autos and LG electronics vulnerable under 25% automobile duties from April 2025. Trump's tariff push, Fortune reports, isn't boosting the economy—manufacturing jobs down 88,000 year-over-year, GDP growth slowed to 2.1% in 2025—yet pressures on Seoul mount as USTR eyes labor rights globally. Korean firms eye onshoring or MFN pricing deals for relief, but with USMCA reviews looming, expect volatility. Thanks for tuning in, listeners—subscribe now for weekly deep dives. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.